At six foot eight, Sen. John Fetterman is still a formidable man, despite two serious assaults on his health in less than a year: he suffered a stroke last May, and after a private struggle for years, ...

Please provide your email address to receive an email when new articles are posted on . Changes in local field potential correlated with reported recovery from MDD ...

Christopher Rozell serves on the scientific advisory board and owns shares in Motif Neurotech, Inc. and is a listed inventor on intellectual property related to this work. He receives funding from NIH ...

Using a novel deep brain stimulation (DBS) device capable of recording brain signals, researchers have identified a pattern of brain activity or “biomarker” related to clinical signs of recovery from ...

New research in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging shows that the brain of individuals who have recovered from depression retains a heightened sensitivity to negative cues, ...

Sen. John Fetterman has faced two major health scares – and quite a bit of public scrutiny – over the last 14 months. In May 2022, just days before the Pennsylvania primary, Fetterman had a stroke ...

A team of leading clinicians, engineers, and neuroscientists has made a groundbreaking discovery in the field of treatment-resistant depression. By analyzing the brain activity of patients undergoing ...

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress ...

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

Teen depression duration varies significantly, with untreated episodes lasting weeks to years, while professional treatment can reduce symptoms within 4-6 weeks and achieve meaningful recovery in 3-12 ...